Regadenoson Infusion of Marginalized Donor Lungs in an EVLP System

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this study is to see if adding a drug called Regadenoson to the EVLP circulation reservoir during perfusion of marginal donor lungs will help increase the likelihood that the donor lungs will become usable for transplantation.
Epistemonikos ID: 2c38eb97174c3e76e0505027a228809e67fd0c8d
First added on: May 07, 2024